Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24019| Title: | Effects of teriflunomide treatment on the CD4(+) T-cell receptor repertoire in patients with relapsing-remitting MS | Authors: | Klotz, Luisa Lindner, Maren Gross, Catherina C. Eschborn, Melanie Posevitz-Fejfar, Anita Schulte-Mecklenbeck, Andreas Meuth, S. G. VAN WIJMEERSCH, Bart Hupperts, Raymond Maeurer, M. Stangel, M. Lang, M. Tackenberg, B. Lysandropoulos, A. Decoo, D. Eveslage, M. Turner, Timothy J. Jagerschmidt, A. Bar-Or, Amit Wiendl, Heinz |
Issue Date: | 2016 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 22, p. 869-869 (Art N° P1646) | Notes: | [Klotz, L.; Lindner, M.; Gross, C. C.; Eschborn, M.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; Meuth, S. G.; Eveslage, M.; Wiendl, H.] Univ Munster, Munster, Germany. [Van Wijmeersch, B.] Hasselt Univ, Hasselt, Belgium. [Hupperts, R.] Maastricht Univ, Maastricht, Netherlands. [Maeurer, M.] Caritas Hosp, Bad Mergentheim, Germany. [Stangel, M.] Hannover Med Sch, Hannover, Germany. [Lang, M.] Neuropoint Patient Acad, Ulm, Germany. [Tackenberg, B.] Philipps Univ, Giessen, Germany. [Tackenberg, B.] Philipps Univ, Marburg, Germany. [Tackenberg, B.] Univ Clin, Giessen, Germany. [Tackenberg, B.] Univ Clin, Marburg, Germany. [Lysandropoulos, A.] Free Univ Brussels, Erasme Hosp, Brussels, Belgium. [Decoo, D.] AZ Alma, Sijsele, Belgium. [Turner, T. J.] Sanofi Genzyme, Cambridge, MA USA. [Jagerschmidt, A.] Sanofi R&D, Chilly Mazarin, France. [Bar-Or, A.] Montreal Neurol Inst, Montreal, PQ, Canada. | Document URI: | http://hdl.handle.net/1942/24019 | ISSN: | 1352-4585 | e-ISSN: | 1477-0970 | ISI #: | 000383267203318 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.